trial · primary record
Cilta-cel
Multiple Myeloma
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 419 |
| Primary completion | 2027-03-31 |
| Primary endpoint | Progression Free Survival (PFS) |
| Registry ID | NCT04181827 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:48.659Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04181827
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Cilta-cel · compound